Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Insulet and other ETFs, options, and stocks.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
James R. Hollingshead
CEOJames R. Hollingshead
Employees
3,000
Employees3,000
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
3,000
Employees3,000

PODD Key Statistics

Market cap
13.12B
Market cap13.12B
Price-Earnings ratio
56.64
Price-Earnings ratio56.64
Dividend yield
Dividend yield
Average volume
1.46M
Average volume1.46M
High today
$188.81
High today$188.81
Low today
$182.80
Low today$182.80
Open price
$185.38
Open price$185.38
Volume
691.88K
Volume691.88K
52 Week high
$313.02
52 Week high$313.02
52 Week low
$125.82
52 Week low$125.82

PODD News

TipRanks 4d
Blue Orca goes short Insulet, sees 'immediate' 15% share drop - TipRanks.com - TipRanks

Blue Orca Capital announced a short position in shares of Insulet (PODD). The firm anticipates an “immediate” 15%-plus drop in shares, saying Insulet will rever...

Benzinga 5d
Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Syste - Benzinga

Loading... Loading... On Tuesday, Blue Orca Capital released a report on Insulet Corporation PODD, saying it is short on the insulin delivery patch pump manufa...

Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Syste - Benzinga
TipRanks 6d
Insulet reports Q1 adjusted EPS 73c, consensus 39c - TipRanks.com - TipRanks

Reports Q1 revenue $441.7M, consensus $424.05M. “We are pleased with our strong first quarter results, which underscore the strength of our advanced technology...

Analyst ratings

88%

of 24 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More PODD News

Benzinga 6d
What the Options Market Tells Us About Insulet - Insulet - Benzinga

Loading... Loading... Deep-pocketed investors have adopted a bullish approach towards Insulet PODD, and it's something market players shouldn't ignore. Our tra...

What the Options Market Tells Us About Insulet - Insulet - Benzinga
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.